Deoxycholic acid cream - SCAI Therapeutics
Alternative Names: SCAI-101Latest Information Update: 31 Mar 2023
At a glance
- Originator SCAI Therapeutics
- Class Choleretics; Cholic acids; Gallstone therapies; Small molecules
- Mechanism of Action Cell membrane modulators; Membrane lipid modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Subcutaneous fat disorders
Most Recent Events
- 22 Feb 2023 Investigation in Subcutaneous fat disorders in South Korea (unspecified route) (SCAI Therapeutics pipeline, February 2023)